Where the dose goes
decides the design.
IntelligenceQ is a London drug delivery company. We design medicines around the tissue they must reach. Three of our own are in preclinical development for the lymphatic system, and we offer partners a four-stage formulation programme that carries their candidate towards a first-in-human application.
Four stages, one formulation.
We keep the formulation chosen at Stage 1 through every stage that follows, so the evidence compounds. Each stage ends in a go or no-go decision, recorded with its reason.
- Assess
GyaniMed, our formulation model, proposes the formulation that will carry your candidate.
- Validate
We test that formulation in cells, then in tissue.
- Locate
We image where the dose goes, organ by organ.
- Package
We package the results for a first-in-human application, and a scientist signs the record.
A pipeline for the lymphatic system.
IQ-101
Therapeutic Pathway Finder
Vaccine Delivery Finder
Discuss licensing with us.
Designed by GyaniMed.
GyaniMed predicts how a formulation will behave, with the uncertainty of each prediction, and designs formulations to a target product profile.
Explore GyaniMedEvery candidate has a destination.
Tell us about your candidate, how far it has come, what is blocking it and the tissue it must reach. Every programme begins at Stage 1.
Investors can write to us about our open seed round. Meet the team.